title: Marked bradycardia due to pulsed and oral methylprednisolone therapy in a patient with rapidly progressive glomerulonephritis.
authors.forename: O
authors.initials: O
authors.lastname: Küçükosmanoğlu
authors.forename: A
authors.initials: A
authors.lastname: Karabay
authors.forename: N
authors.initials: N
authors.lastname: Ozbarlas
authors.forename: A
authors.initials: A
authors.lastname: Noyan
authors.forename: A
authors.initials: A
authors.lastname: Anarat
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D001919:Bradycardia / Q000139:chemically induced* / Q000628:therapy; D002304:Cardiac Pacing, Artificial; D018450:Disease Progression; D004334:Drug Administration Schedule; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000473:pathology; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D005938:Glucocorticoids; D008775:Methylprednisolone